About H.U. Group Holdings
H.U. Group Holdings is a company based in Shinjuku (Japan) founded in 1950. The company has 5,440 employees as of March 31, 2024. H.U. Group Holdings operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, DM Clinical and IPHARMA, among others.
- Headquarter Shinjuku, Japan
- Employees 5440 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name H.U.Group Holdings, Inc.
-
Annual Revenue
$1.63 B (USD)2.56as on Mar 31, 2025
-
Net Profit
$18.47 M (USD)0as on Mar 31, 2025
-
EBITDA
$154.52 M (USD)37.24as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
5440
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of H.U. Group Holdings
H.U. Group Holdings is a publicly listed company on the TSE with ticker symbol 4544 in Japan, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of H.U. Group Holdings
Detailed funding history for H.U. Group Holdings
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by H.U. Group Holdings
Investment portfolio details for H.U. Group Holdings
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - H.U. Group Holdings
Detailed financials for H.U. Group Holdings
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
H.U. Group Holdings Comparisons
Peer comparison for H.U. Group Holdings
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of H.U. Group Holdings
H.U. Group Holdings operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, DM Clinical and IPHARMA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO providing diversified clinical development services
|
|
| Locked | Locked | Locked |
Medicines and therapies are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
|
|
| Locked | Locked | Locked |
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
|
|
| Locked | Locked | Locked |
Serves as a contract research organization focused on drug clinical trials.
|
Detailed competitors of H.U. Group Holdings
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on H.U. Group Holdings
Complete news archive for H.U. Group Holdings
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about H.U. Group Holdings
H.U. Group Holdings was founded in 1950.
H.U. Group Holdings is headquartered in Shinjuku, Japan. It is registered at Shinjuku, Tokyo, Japan.
As of Mar 31, 2024, the latest employee count at H.U. Group Holdings is 5,440.
Annual revenue of H.U. Group Holdings is $1.63B as on Mar 31, 2025.
H.U. Group Holdings was founded in 1950 and is headquartered in Shinjuku, Japan. Operations in the healthcare sector focus on laboratory testing, in-vitro diagnostics, and related services. Research and development efforts support clinical laboratory medicine and technological progress in medical science. Intellectual property management is handled, alongside initiatives for public health issues. Services extend to broader healthcare support across the region.
H.U. Group Holdings's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.
Yes, H.U. Group Holdings is publicly traded on TSE under the ticker symbol 4544.
The ticker symbol of H.U. Group Holdings is 4544 on TSE.